Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 1,731,946	$ 1,763,114
Accounts receivable	83,287	41,431
Inventories	25,620	37,435
Prepaid expenses and other current assets	32,254	49,167
Total current assets	1,873,107	1,891,147
Equipment, net of depreciation	55,009
Other non-current assets, net of amortization	39,459	19,157
Total assets	1,967,575	1,910,304
Current liabilities:
Accounts payable and accrued expenses	290,076	324,983
Accrued officer bonus	100,000
Convertible notes	280,000
Discount on convertible notes payable	(78,826)
Derivative warrant liability	303,880
Deposits		135,000
Total current liabilities	831,243	459,983
Long-term liabilities:
Aggregate Investments	5,117,876	3,245,972
Line of credit	50,000
Discount on convertible notes payable and line of credit	(3,871,450)	(2,937,019)
Total liabilities	2,127,669	768,936
STOCKHOLDERS’ EQUITY (DEFICIT):
Convertible Preferred Series A, $.00067 Par Value, 50,000,000 Shares Authorized, -0- Shares Issued and Outstanding, at December 31, 2015 and September 30, 2016, respectively.	0	0
Common stock, $.00067 Par Value, 200,000,000 Shares Authorized, 85,648,015 and 89,915,980 Shares Issued, at December 31, 2015 and September 30, 2016, respectively.	60,114	57,236
Additional paid-in capital	88,925,035	84,410,821
Accumulated deficit	(89,680,852)	(84,075,695)
Accumulated other comprehensive loss	(62,290)	(40,567)
Non-controlling interest (Note 8)	597,899	789,573
Total stockholders’ equity (deficit)	(160,094)	1,141,368
Total liabilities and stockholders’ equity	$ 1,967,575	$ 1,910,304